Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Monday, BioAmber (NYSE:BIOA)'s Director, Kurt W. Briner, made a $163,875 purchase of BIOA, buying 14,250 shares at a cost of $11.50 each. So far Briner is in the green, up about 5.7% on their purchase based on today's trading high of $12.15. BioAmber is trading trading flat on the day Tuesday. Before this latest buy, Briner purchased BIOA on 2 other occasions during the past year, for a total investment of $36,418 at an average of $11.45 per share.
And at Cascade Bancorp (CACB), there was insider buying on Thursday, by EVP-Chief Credit Officer Daniel J. Lee who bought 25,000 shares for a cost of $5.34 each, for a total investment of $133,448. Before this latest buy, Lee bought CACB on 2 other occasions during the past twelve months, for a total investment of $177,387 at an average of $4.34 per share. Cascade Bancorp is trading off about 0.4% on the day Tuesday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.